Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the Un-Audited Standalone & Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has informed BSE that its Board of Directors will meet on Friday, February 13, 2026, at the registered office. The agenda includes considering and approving the Un-Audited Standalone and Consolidated Financial Results for the third quarter and nine months ended December 31, 2025. The company has also closed its trading window for directors, promoters, designated employees, and connected persons until February 15, 2026, in compliance with insider trading norms.
This is a routine pre-results announcement. No new financial information is disclosed yet; investors should watch for the actual Q3 results on or after February 13, 2026, which could move the stock depending on performance versus expectations.